Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients.

Chaiho JeongHee-Je KimSeok LeeMoo Il KangJeonghoon Ha

Published in: International journal of endocrinology (2020)

Denosumab improved bone mineral density in haematopoietic stem cell transplantation recipients. The use of denosumab could be a good therapeutic option without causing severe adverse effects in recipients of haematopoietic transplantation.

Keyphrases

bone mineral density
stem cell transplantation
postmenopausal women
body composition
kidney transplantation
high dose
acute myeloid leukemia
early onset
stem cells
mesenchymal stem cells